207 related articles for article (PubMed ID: 29737071)
1. [Health Utility of Patients with Stroke Measured by EQ-5D and SF-6D].
Du XD; Zhu P; Li ME; Wang J; Meng HD; Zhu CR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Mar; 49(2):252-257. PubMed ID: 29737071
[TBL] [Abstract][Full Text] [Related]
2. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
[TBL] [Abstract][Full Text] [Related]
3. Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients.
Zhao FL; Yue M; Yang H; Wang T; Wu JH; Li SC
Value Health; 2010 Aug; 13(5):649-56. PubMed ID: 20412540
[TBL] [Abstract][Full Text] [Related]
4. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.
Thaweethamcharoen T; Noparatayaporn P; Sritippayawan S; Aiyasanon N
Value Health Reg Issues; 2019 May; 18():59-64. PubMed ID: 30502661
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.
Xie F; Li SC; Luo N; Lo NN; Yeo SJ; Yang KY; Fong KY; Thumboo J
Arthritis Rheum; 2007 Aug; 57(6):1043-9. PubMed ID: 17665466
[TBL] [Abstract][Full Text] [Related]
6. Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients.
Wu J; Han Y; Zhao FL; Zhou J; Chen Z; Sun H
Health Qual Life Outcomes; 2014 Oct; 12():156. PubMed ID: 25343944
[TBL] [Abstract][Full Text] [Related]
7. A comparison of four different approaches to measuring health utility in depressed patients.
Turner N; Campbell J; Peters TJ; Wiles N; Hollinghurst S
Health Qual Life Outcomes; 2013 May; 11():81. PubMed ID: 23659557
[TBL] [Abstract][Full Text] [Related]
8. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M
J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412
[TBL] [Abstract][Full Text] [Related]
9. EQ-5D and SF-6D health utility scores in patients with spinal and bulbar muscular atrophy.
Xu RH; Lu M; Zhang S; Dong D
Eur J Health Econ; 2023 Nov; 24(8):1399-1410. PubMed ID: 36418784
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.
Gaujoux-Viala C; Rat AC; Guillemin F; Flipo RM; Fardellone P; Bourgeois P; Fautrel B
J Rheumatol; 2011 Aug; 38(8):1576-84. PubMed ID: 21532054
[TBL] [Abstract][Full Text] [Related]
11. Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population.
Selva-Sevilla C; Ferrara P; Gerónimo-Pardo M
Eur J Health Econ; 2020 Jun; 21(4):649-662. PubMed ID: 32065301
[TBL] [Abstract][Full Text] [Related]
12. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
[TBL] [Abstract][Full Text] [Related]
13. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
Petrou S; Hockley C
Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia.
Xu RH; Dong D; Luo N; Wong EL; Wu Y; Yu S; Yang R; Liu J; Yuan H; Zhang S
Eur J Health Econ; 2021 Jun; 22(4):547-557. PubMed ID: 33761029
[TBL] [Abstract][Full Text] [Related]
15. The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure.
Kontodimopoulos N; Argiriou M; Theakos N; Niakas D
Eur J Health Econ; 2011 Aug; 12(4):383-91. PubMed ID: 20473544
[TBL] [Abstract][Full Text] [Related]
16. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
Wong CKH; Lang BHH; Yu HMS; Lam CLK
Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the measurement properties and estimation of minimal important differences of the EQ-5D and SF-6D utility measures in patients with systemic sclerosis.
Kwakkenbos L; Fransen J; Vonk MC; Becker ES; Jeurissen M; van den Hoogen FH; van den Ende CH
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):50-6. PubMed ID: 23910610
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the psychometric properties of the EQ-5D-3L and SF-6D in the general population of Chengdu city in China.
Zhao L; Liu X; Liu D; He Y; Liu Z; Li N
Medicine (Baltimore); 2019 Mar; 98(11):e14719. PubMed ID: 30882636
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of Chinese medicine quality of life assessment scale (CQ-11D) and EQ-5D-5L and SF-6D scales based on Chinese population.
Zhou J; Xu L; Pan J; Wang M; Zhou P; Wang W; Lu S; Zhu W
Qual Life Res; 2024 Jan; 33(1):113-122. PubMed ID: 37695478
[TBL] [Abstract][Full Text] [Related]
20. Comparison of EuroQol-5D and short form-6D utility scores in multiethnic Asian patients with psoriatic arthritis: a cross-sectional study.
Leung YY; Png ME; Wee HL; Thumboo J
J Rheumatol; 2013 Jun; 40(6):859-65. PubMed ID: 23504382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]